PaulAGoepfertMD
Infectious Disease • Birmingham, ALProfessor, Medicine, University of Alabama School of Medicine
Dr. Goepfert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
619 19th Street South
Birmingham, AL 35233Phone+1 205-934-6600- Is this information wrong?
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 1994 - 1997- University of Alabama Medical CenterResidency, Internal Medicine, 1991 - 1994
Baylor College of MedicineClass of 1991
Certifications & Licensure
AL State Medical License 1992 - 2023
TX State Medical License 1992 - 1997- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Clinical Trials
- Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults
- Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth Start of enrollment: 2002 Dec 01
- Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans.Anoma Nellore, Esther Zumaquero, Christopher D Scharer, Christopher F Fucile, Christopher M Tipton, R Glenn King, Tian Mi, Betty Mousseau, John E Bradley, Fen Zhou, St...> ;Immunity. 2023 Apr 11
- Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults.Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, Karina Yusim, Nicole Frahm, Marnie L Elizaga, Janine Maenza, Hyman Scott, Kenneth H Mayer, Paul A Goepfert, Sr...> ;The Journal of Clinical Investigation. 2023 Feb 15
- 1 citationsRapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.Alfredo J Mena Lora, Jessica E Long, Yunda Huang, Lindsey R Baden, Hana M El Sahly, Dean Follmann, Paul Goepfert, Glenda Gray, Beatriz Grinsztejn, Karen Kotloff, Nadin...> ;JAMA Network Open. 2023 Jan 3
- Join now to see all
Press Mentions
HIV Vaccine Design Should Adapt as HIV MutatesMay 16th, 2016
GeoVax Announces Further Positive Results of Its HIV Preventive Vaccine Program at International HIV Research ConferenceOctober 24th, 2018
Pneumonia Vaccine Said to Reduce U.S. HospitalizationsJuly 10th, 2013- Join now to see all
Grant Support
- CTL And HIV Polymorphisms In Heterosexual TransmissionNational Institute Of Allergy And Infectious Diseases2010–2012
- HIV-1 Cryptic Epitopes: Implications For Vaccine DesignNational Institute Of Allergy And Infectious Diseases2009–2011
- ClinicalNational Institute Of Allergy And Infectious Diseases2008–2011
- HIV-1 Suppression By MHC Class I Restricted CD8 T CellsNational Institute Of Allergy And Infectious Diseases2007–2008
- Alabama/Zambia HIV Vaccine Clinical Trials Unit (HVTU)National Institute Of Allergy And Infectious Diseases2004–2006
- CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2002–2005
- CD8+ T Cell Cytokine Production In HIV-1 InfectionNational Institute Of Allergy And Infectious Diseases2001
- Human Foamy Virus Structural ProteinsNational Institute Of Allergy And Infectious Diseases1996–2000
Hospital Affiliations
Birmingham Veterans Affairs Medical CenterBirmingham, Alabama
University of Alabama HospitalBirmingham, Alabama
USA Health University HospitalMobile, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
